Predictors of the Overall Survival with Azacitidine Monotherapy in Untreated Acute Myeloid Leukemia Patients Ineligible for Intensive Therapy

OBJECTIVE: The prognostic factors for azacitidine in untreated acute myeloid leukemia (AML) patients ineligible for intensive therapy remain unknown. To identify prognostic factors for azacitidine monotherapy and assist clinicians in deciding whether to use azacitidine monotherapy or other therapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Taenaka, Ryutaro, Obara, Teppei, Kohno, Kentaro, Aoki, Kenichi, Ogawa, Ryosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037016/
https://www.ncbi.nlm.nih.gov/pubmed/35871587
http://dx.doi.org/10.2169/internalmedicine.0264-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037016/
https://www.ncbi.nlm.nih.gov/pubmed/35871587
http://dx.doi.org/10.2169/internalmedicine.0264-22

Ejemplares similares